Statin Use and the Risk of Graves' Orbitopathy: A Nationwide Population-Based Cohort Study.

Statin use is reported to reduce the risk of Graves' orbitopathy (GO) in Western populations. However, study regarding the protective effect of statins against GO in Asians with Graves' disease (GD) is scarce. This study aims to investigate the efficacy of statins in preventing GO in Asian GD patients.

CRISPR/Cas9-mediated mutation provides a new insight into resveratrol biosynthesis by causing a metabolic pathway shift from flavonoids to stilbenoids in cells.

Resveratrol is an important phytoalexin that adapts to and responds to stressful conditions and plays various roles in health and medical therapies. However, it is only found in a limited number of plant species in low concentrations, which hinders its development and utilization. Chalcone synthase (CHS) and stilbene synthase (STS) catalyze the same substrates to produce flavonoids and resveratrol, respectively.

Optimizing the Coordination Energy of Co-N Sites by Co Nanoparticles Integrated with Fe-NCNTs for Boosting PEMFC and Zn-Air Battery Performance.

Enhancing the catalytic performance and durability of M-N─C catalyst is crucial for the efficient operation of proton exchange membrane fuel cells (PEMFCs) and Zn-Air batteries (ZABs). Herein, an approach is developed for the in situ fabrication of a MOFs-derived porous carbon material, co-loaded with Co nanoparticles (NPs) and Co-N sites and integrated onto Fe-doped carbon nanotubes (CNTs), named Co-NC/Fe-NCNTs. Incorporating polymer-wrapped CNTs improves MOFs dispersion annealing at high temperature, which amplifies the three-phase boundary (TPB) by generating much more mesopores and exposing additional active sites within the catalysts layer.

Synergistic effect of repurposed mitomycin C in combination with antibiotics against Aeromonas infection: In vitro and in vivo studies.

Background: Aeromonas infections pose a significant threat associated with high mortality rates. This study investigates the potential of mitomycin C (MMC), an anticancer drug, as a novel antimicrobial agent against Aeromonas infections.

Methods: We evaluated the minimum inhibitory concentrations (MICs) of MMC and antibiotics against clinical Aeromonas isolates using broth microdilution.